SARS‐CoV‐2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup
Icahn School of Medicine at Mount Sinai · BOKU University
Abstract
In late 2019, cases of atypical pneumonia were detected in China. The etiological agent was quickly identified as a betacoronavirus (named SARS-CoV-2), which has since caused a pandemic. Several methods allowing for the specific detection of viral nucleic acids have been established, but these only allow detection of the virus during a short period of time, generally during acute infection. Serological assays are urgently needed to conduct serosurveys, to understand the antibody responses mounted in response to the virus, and to identify individuals who are potentially immune to re-infection. Here we describe a detailed protocol for expression of antigens derived from the spike protein of SARS-CoV-2 that can…
Citation impact
- FWCI
- 18.48
- Percentile
- 100%
- References
- 17
Authors
16- DSDaniel StadlbauerCorresponding
Icahn School of Medicine at Mount Sinai
- FAFatima Amanat
Icahn School of Medicine at Mount Sinai
- VCVeronika Chromikova
Icahn School of Medicine at Mount Sinai
- KJKaijun Jiang
Icahn School of Medicine at Mount Sinai
- SSShirin Strohmeier
BOKU University, Icahn School of Medicine at Mount Sinai
Topics & keywords
- Serology
- Biology
- Seroconversion
- Virology
- Antigen
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- Test (biology)
- Coronavirus disease 2019 (COVID-19)
- Good health and well-being